Why is Welcure Drugs falling/rising?

As of 13-Nov, Welcure Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 0.64, which reflects a rise of 0.03 or 4.92%. The stock has shown strong performance today, outperforming its sector by 4.71% and achieving consecutive gains for the last six days, resulting in a total return of 25.49% during this period. Additionally, the stock's one-week performance is notably positive at +20.75%, although it has faced declines over the longer term, with a year-to-date drop of 39.07%. The rising investor participation is evident, with a delivery volume of 88.78 lacs on 12 Nov, which is 9.24% higher than the 5-day average, indicating increased interest in trading the stock. There are no specific positive or negative factors available to further contextualize this movement.
Broader market context shows that while Welcure Drugs has outperformed the Sensex by a significant margin in the short term, with a 1-week return of +20.75% compared to the Sensex's +1.40%, it has struggled over longer periods, such as a 1-month decline of 11.66% versus the Sensex's gain of 2.61%. This contrast highlights the stock's volatility and potential recovery phase in the short term, despite its overall negative performance year-to-date and over the past year.